The Medicine Maker

Business & Regulation Business Practice Drug Delivery Ingredients Formulation Quality & Compliance Standards & Regulation Trends & Forecasts Business & Trends Drug Delivery Formulation Regulation & Standards

Studying low-affinity fragments of ligands by ITC

August 20, 2015

1 min read

Studying low-affinity fragments of ligands by ITC

Manufacture Business Practice Clinical Trials Drug Delivery Formulation Standards & Regulation Small Molecules Trends & Forecasts Business & Trends Development & Clinical Drug Delivery Formulation Regulation & Standards Small Molecules

Nanoparticle Tracking Analysis: Principles and Methodology

August 20, 2015

Nanoparticle Tracking Analysis represents a rapid and information-rich multi-parameter nanoparticle characterization technique allowing the user to obtain number frequency particle size distributions of polydisperse nanoparticulate systems. It has resulted in its rapid adoption as an interesting new technique in a wide range of sectors within the pharmaceutical sciences. This Chapter 5 addresses some of the latest work reported in the literature in which NTA has been proposed, used and assessed in the study of nanoparticle-based drug delivery and targeting.

1 min read

Nanoparticle Tracking Analysis: Principles and Methodology

Manufacture Business Practice Clinical Trials Drug Delivery Ingredients Formulation Small Molecules Trends & Forecasts Business & Trends Development & Clinical Drug Delivery Formulation Small Molecules

Laser diffraction and automated imaging: complementary techniques for nasal spray development

August 20, 2015

1 min read

$Laser diffraction and automated imaging: complementary techniques for nasal spray development$

Business & Regulation Formulation Business Practice Drug Delivery Standards & Regulation Trends & Forecasts Formulation Business & Trends Drug Delivery Regulation & Standards

A Cat and Mouse Game: The Evolving Landscape of Abuse-Deterrent Formulations

August 6, 2015

Abusers are finding ways to circumvent current abuse-deterrent measures, leaving companies in need of new strategies. Alyn McNaughton, Director of Analytical and Product Development at Encap Drug Delivery, a division of Capsugel Dosage Form Solutions, and Shonagh Walker, Formulation Scientist at Encap Drug Delivery, talk us through some of the challenges.

1 min read

A Cat and Mouse Game: The Evolving Landscape of Abuse-Deterrent Formulations

Manufacture Small Molecules Small Molecules

Decision Support

August 6, 2015

Suzanne Farid is Professor of Bioprocess Systems Engineering and Co-Director of the ESPSRC Center for Innovative Manufacturing in Emergent Macromolecule Therapies hosted by the Department of Biochemical Engineering at University College London. Farid and her team have developed a range of software tools to help biopharma companies make decisions on the best manufacturing processes, including whether to make the switch to continuous.

1 min read

Manufacture Small Molecules Small Molecules

Recall Roundup

August 6, 2015

Several companies are faced with recall woes thanks to insects, dodgy closures and broken tablets

1 min read

Manufacture Small Molecules Small Molecules

Is Biopharma Ready to Say Goodbye to Batches?

August 6, 2015

Very few biologics are made using continuous processing equipment like bioreactors. Clearly, the biopharmaceutical industry has a long way to go before it’s ready to embrace (potentially) superior manufacturing models. Why?

1 min read

Is Biopharma Ready to Say Goodbye to Batches?

Discovery & Development Standards & Regulation Analytical Science Regulation & Standards Business & Trends Sponsored

Holistic Bioanalytics in the Clinic

August 6, 2015

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt. Now, as director of the University of Florida’s Center for Pharmacometrics and Systems Pharmacology, Larry uses metabolomics to discover biomarkers of drug toxicity.

1 min read

Business & Regulation